CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 76 enrolled
Drug / intervention
CPAP ATother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03281993
NCT03281993N/ACompleted
CompareCT.gov

Alternative Apnea Test as the Method of Brain Death Diagnosis .

Pomeranian Medical University Szczecin·observational·Posted Sep 13, 2017·Updated Sep 14, 2017

In Brief

An observational study evaluating CPAP AT for Brain Death and 2 related conditions. Completed, enrolled 76 participants.

Detailed Summary

Apnea test (AT) is the most important clinical test performed usually at the end of brain death (BD) diagnosis procedure. Traditional insufflation apnea test (I-AT) cannot be completed in patients with extremely compromised lung function due to rapid blood desaturation and circulatory disturbances. Therefore the investigators decided to verify alternative AT options such as continuous positive airway pressure apnea test (CPAP-AT) in patients with good and poor baseline oxygenation, before implementing them in currently reviewed Polish BD criteria.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBrain Death, Apnea, Pupillary Anomaly
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 13, 2017
Enrollment StartJun 25, 2015
Primary CompletionJun 25, 2015
Study CompletionJun 25, 2017
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 8.8 years ago

Interventions

CPAP ATother

If the investigators observe rapid desaturation defined as a decline in O2 saturation below 85%; the CPAP apnea test (CPAP-AT) test was aborted.